4-Chloro-1-iodo-2-methylbenzene - CAS 23399-70-4
Catalog: |
BB018041 |
Product Name: |
4-Chloro-1-iodo-2-methylbenzene |
CAS: |
23399-70-4 |
Synonyms: |
4-chloro-1-iodo-2-methylbenzene; 4-chloro-1-iodo-2-methylbenzene |
IUPAC Name: | 4-chloro-1-iodo-2-methylbenzene |
Description: | 4-Chloro-1-iodo-2-methylbenzene (CAS# 23399-70-4) is a useful research chemical. |
Molecular Weight: | 252.48 |
Molecular Formula: | C7H6ClI |
Canonical SMILES: | CC1=C(C=CC(=C1)Cl)I |
InChI: | InChI=1S/C7H6ClI/c1-5-4-6(8)2-3-7(5)9/h2-4H,1H3 |
InChI Key: | ZZNUQVQAJVZRKW-UHFFFAOYSA-N |
Boiling Point: | 240 °C at 760 mmHg |
Density: | 1.806 g/cm3 |
MDL: | MFCD00060665 |
LogP: | 3.25300 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2020083855-A1 | Novel tricyclic compounds for the treatment and prophylaxis of hepatitis b virus disease | 20181024 |
CN-112888480-A | Novel tricyclic compounds for the treatment and prevention of hepatitis b virus diseases | 20181024 |
EP-3870295-A1 | Novel tricyclic compounds for the treatment and prophylaxis of hepatitis b virus disease | 20181024 |
CN-108863894-B | Method for directly synthesizing indole from nitrile | 20180810 |
WO-2020020777-A1 | Use of substituted 2-thiazolines as nitrification inhibitors | 20180723 |
Complexity: | 94.9 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 251.92028 |
Formal Charge: | 0 |
Heavy Atom Count: | 9 |
Hydrogen Bond Acceptor Count: | 0 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 251.92028 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 0 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 4.1 |
-
Catalog: BB054190
(-)-(8,8-Dichlorocamphorylsulfonyl)oxaziridine
Detail
-
Catalog: BB054256
((2S,4R)-2-((1H-1,2,4-Triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methanol
Detail
-
Catalog: BB045655
((5-[(4-Chloro-3-methyl-1H-pyrazol-1-yl)methyl]-4-ethyl-4H-1,2,4-triazol-3-yl)thio)acetic acid
Detail
-
Catalog: BB079620
((4-bromo-3-(bromomethyl)butoxy)methyl)benzene
Detail
-
Catalog: BB047664
(1E)-3-(4-Chloro-1H-pyrazol-1-yl)-N'-hydroxy-2-methylpropanimidamide
Detail
-
Catalog: BB052123
(1-Isopropyl-1H-pyrazol-5-yl)methanamine hydrochloride
Detail
-
Catalog: BB044157
(+)-2,10-(3,3-dichlorocamphorsultam)
Detail
-
Catalog: BB051699
(1-(2,2-Difluoroethyl)-1H-pyrazol-4-yl)methanamine hydrochloride
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Halides
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS